search
Back to results

Evaluate the Safety and Efficacy of a Steerable Catheter in the Treatment of Vascular Interventional Access

Primary Purpose

Peripheral Vascular Diseases

Status
Completed
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
steerable catheter
Sponsored by
Hangzhou Wei Qiang Medical Technology Co., Ltd.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Peripheral Vascular Diseases

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • age from 18 to 80, male or female.
  • Complying with the standard of peripheral vascular interventional operation treatment , complying with the standard treatment of vascular angiogram, need to establish vascular interventional treatment access.
  • The subject who is able to understand the test purpose, voluntarily join this clinical trial with informed consent forms.

Exclusion Criteria:

  • Patients with cerebrovascular accident or major gastrointestinal bleeding in six months unable to carry out antithrombotic therapy because of having contraindications to antiplatelet agents and anticoagulants and have haemorrhage tendency
  • Hypohepatia, hematuria, deep vein thrombosis, and/or receiving the immunosuppressant therapy
  • The distal target vessel blood flow low may produce thrombosis
  • The women who pregnancy, lactation and can't contraception during the trial period
  • Patients has been involved in other drugs or medical devices clinical trials related to treatment of the target lesion or has been involved in other drugs or medical device clinical trials but have not reached the primary endpoint of the study
  • Patients unable or unwilling to participate in this trial
  • the researcher determine the patient is not suitable to participate in clinical research

Sites / Locations

  • Zhongshan hospital Fudan University

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

steerable catheter

Arm Description

to study the safety and efficacy of a steerable catheter in the treatment of peripheral vascular disease

Outcomes

Primary Outcome Measures

procedure success rate
The procedure success rate should fulfill the following three point at the same time:1 the steerable catheter can assist the guiding wire into the target vascular. 2 the steerable catheter can follow the guiding wire into the target vascular. 3 the steerable catheter can remove from the subject successfully.

Secondary Outcome Measures

the steerable catheter compliance during the procedure of catheter access into the target vascular
evaluate with excellent, good , general, poor four levels (according to surgeons experience to score)
the steerable catheter directivity during the procedure of catheter access into the target vascular
evaluate with excellent, good , general, poor four levels (according to surgeons experience to score)
the steerable catheter visibility under the X-ray during the procedure of catheter access into the target vascular
evaluate with excellent, good , general, poor four levels (according to surgeons experience to score)

Full Information

First Posted
June 13, 2017
Last Updated
March 20, 2018
Sponsor
Hangzhou Wei Qiang Medical Technology Co., Ltd.
search

1. Study Identification

Unique Protocol Identification Number
NCT03191500
Brief Title
Evaluate the Safety and Efficacy of a Steerable Catheter in the Treatment of Vascular Interventional Access
Official Title
Evaluate the Safety and Efficacy of a Steerable Catheter in the Treatment of Vascular Interventional Access : a Prospective, Muti-center, Single-arm Study
Study Type
Interventional

2. Study Status

Record Verification Date
March 2018
Overall Recruitment Status
Completed
Study Start Date
July 11, 2017 (Actual)
Primary Completion Date
November 27, 2017 (Actual)
Study Completion Date
December 31, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hangzhou Wei Qiang Medical Technology Co., Ltd.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
This is a prospective, multicenter, single-arm clinical trial to evaluate safety and efficacy of a steerable catheter in the establishment of vascular intervention access. five centers participate in this study. The total enrollment number is 68. In the procedure of vascular interventional surgery or angiography diagnosis, the steerable catheter are used to building vascular interventional access. Evaluate the safety and efficacy of the product, by the observation and record the relative index of subjects intraoperative and postoperative (discharge) before and after 30 days .
Detailed Description
This is a prospective, multicenter, single-arm clinical trial to evaluate safety and efficacy of a steerable catheter in the establishment of vascular intervention access. five centers participate in this study. The total enrollment number is 68. In the procedure of vascular interventional surgery or angiography diagnosis, the steerable catheter are used to building vascular interventional access. Evaluate the safety and efficacy of the product, by the observation and record the relative index(like catheter compliance, catheter directivity, and catheter visibility under X ray) of subjects in the procedure, telephone follow up at 30 days investigate the subjects healthy condition.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Peripheral Vascular Diseases

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
72 (Actual)

8. Arms, Groups, and Interventions

Arm Title
steerable catheter
Arm Type
Experimental
Arm Description
to study the safety and efficacy of a steerable catheter in the treatment of peripheral vascular disease
Intervention Type
Device
Intervention Name(s)
steerable catheter
Intervention Description
peripheral vascular disease
Primary Outcome Measure Information:
Title
procedure success rate
Description
The procedure success rate should fulfill the following three point at the same time:1 the steerable catheter can assist the guiding wire into the target vascular. 2 the steerable catheter can follow the guiding wire into the target vascular. 3 the steerable catheter can remove from the subject successfully.
Time Frame
during the procedure
Secondary Outcome Measure Information:
Title
the steerable catheter compliance during the procedure of catheter access into the target vascular
Description
evaluate with excellent, good , general, poor four levels (according to surgeons experience to score)
Time Frame
during the procedure
Title
the steerable catheter directivity during the procedure of catheter access into the target vascular
Description
evaluate with excellent, good , general, poor four levels (according to surgeons experience to score)
Time Frame
during the procedure
Title
the steerable catheter visibility under the X-ray during the procedure of catheter access into the target vascular
Description
evaluate with excellent, good , general, poor four levels (according to surgeons experience to score)
Time Frame
during the procedure

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: age from 18 to 80, male or female. Complying with the standard of peripheral vascular interventional operation treatment , complying with the standard treatment of vascular angiogram, need to establish vascular interventional treatment access. The subject who is able to understand the test purpose, voluntarily join this clinical trial with informed consent forms. Exclusion Criteria: Patients with cerebrovascular accident or major gastrointestinal bleeding in six months unable to carry out antithrombotic therapy because of having contraindications to antiplatelet agents and anticoagulants and have haemorrhage tendency Hypohepatia, hematuria, deep vein thrombosis, and/or receiving the immunosuppressant therapy The distal target vessel blood flow low may produce thrombosis The women who pregnancy, lactation and can't contraception during the trial period Patients has been involved in other drugs or medical devices clinical trials related to treatment of the target lesion or has been involved in other drugs or medical device clinical trials but have not reached the primary endpoint of the study Patients unable or unwilling to participate in this trial the researcher determine the patient is not suitable to participate in clinical research
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Weiguo Fu, MD
Organizational Affiliation
Fudan University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Zhongshan hospital Fudan University
City
Shanghai
State/Province
Shanghai
ZIP/Postal Code
200032
Country
China

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Evaluate the Safety and Efficacy of a Steerable Catheter in the Treatment of Vascular Interventional Access

We'll reach out to this number within 24 hrs